<sup>18</sup>F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer.

Mesci, Aruz; Ahmadi, Elham; Ali, Amr; Gouran-Savadkoohi, Mohammad; Evelyn Tsakiridis, Evangelia; Biziotis, Olga-Demetra; Chow, Tom; Kapoor, Anil; Sur, Monalisa; Steinberg, Gregory R; Liu, Stanley; Zukotynski, Katherine; Tsakiridis, Theodoros

¹⁸F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer.

Mesci, Aruz; Ahmadi, Elham; Ali, Amr; Gouran-Savadkoohi, Mohammad; Evelyn Tsakiridis, Evangelia; Biziotis, Olga-Demetra; Chow, Tom; Kapoor, Anil; Sur, Monalisa; Steinberg, Gregory R; Liu, Stanley; Zukotynski, Katherine; Tsakiridis, Theodoros.

Afiliação

Mesci A; Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada.
Ahmadi E; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.
Ali A; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.
Gouran-Savadkoohi M; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Evelyn Tsakiridis E; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.
Biziotis OD; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Chow T; Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada.
Kapoor A; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.
Sur M; Dept. of Medicine, McMaster University, Hamilton, Ontario, Canada.
Steinberg GR; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Liu S; Dept. of Oncology, McMaster University, Hamilton, Ontario, Canada.
Zukotynski K; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
Tsakiridis T; Physics, Juravinski Cancer Centre, Hamilton Health Sciences, Ontario, Canada.

Clin Transl Radiat Oncol ; 39: 100583, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36713978

Palavras-chave

ADT, Androgen Deprivation Therapy; AMACR, Alpha-Methylacyl-CoA Racemase; ARAT, Androgen Receptor Axis-Targeted; BED, Biological Effective Dose; CRPC, Castration Resistant Prostate Cancer; FOLH1 expression; FOLH1, Folate Hydrolase 1; H&E, Hematoxylin and Eosin; H-Score, Histologic Score; HSPC, Hormone Sensitive Prostate Cancer; IHC, Immunohistochemistry; Immunohistochemistry; LHRH, Luteinizing Hormone Releasing Hormone; MDRT, Metastasis Directed Radiotherapy; NH, Hormone Naïve; P-H3, Phosphorylated Histone-H3; PET, Positron Emission Tomography; PSA, Prostate Specific Antigen; PSMA, Prostate Specific Membrane Antigen; PSMA-PET; PrCa, Prostate Cancer; RP, Radical Prostatectomy; RT, Radiation Therapy; Radio-resistance; Rec, Recurrence; SUV, Standardized Uptake Value; Tumor heterogeneity; mCRPC, Metastatic Castration Resistant Prostate Cancer; mRNA, Messenger Ribonucleic Acid; qPCR; qPCR, Quantitative Polymerase Chain Reaction

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google